NCT06779942View on ClinicalTrials.gov

The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure

CompletedOBSERVATIONAL

Enrollment

414

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Acute Respiratory Distress Syndrome (ARDS)Acute Respiratory Failure (ARF)

Trial Locations (2)

75475

Hôpital Saint Louis, Paris

Unknown

University Paris Diderot, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT06779942 - The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure | Biotech Hunter | Biotech Hunter